{"name":"Genzyme Ventures","permalink":"genzyme-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/genzyme-ventures","homepage_url":"http://www.genzyme.com","blog_url":"","blog_feed_url":"","twitter_username":null,"phone_number":"617 252 7500","description":null,"email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":"biotechnology, serious-diseases, inherited-disorders, kidney-disease, orthopaedics, cancer, transplant","alias_list":null,"created_at":"Wed May 21 22:11:39 UTC 2008","updated_at":"Sun Nov 16 09:13:29 UTC 2008","overview":"<p>Genzyme Ventures is a corporate venture capital fund dedicated to helping Genzyme Corporation achieve its strategic goals. Founded in 2001, the $100 million fund has a current portfolio of direct corporate investments and has taken LP positions in funds managed by life-science focused VC firms. Through its direct investments in private early-stage companies, the fund aims to forge relationships which may lead to larger collaborations in the future. Genzyme Ventures is able to leverage the entire Genzyme organization, including its global experience and expertise in R&amp;D, reimbursement, and commercialization, to provide portfolio companies with invaluable advice and assistance. Its Limited Partnership investments provide insight into the broader healthcare innovation landscape.</p>","image":{"available_sizes":[[[150,50],"assets/images/resized/0002/8655/28655v1-max-150x150.png"],[[155,52],"assets/images/resized/0002/8655/28655v1-max-250x250.png"],[[155,52],"assets/images/resized/0002/8655/28655v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"500 Kendall Street ","address2":"","zip_code":"02142","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":42.3640302,"longitude":-71.0818192},{"description":"","address1":"One Mountain Road","address2":"","zip_code":"01701","city":"Framingham","state_code":"MA","country_code":"USA","latitude":42.3014032,"longitude":-71.4811498},{"description":"","address1":"Gooimeer 10","address2":"","zip_code":"1411 DD","city":"NAARDEN","state_code":null,"country_code":"NLD","latitude":52.3076408,"longitude":5.141957}],"relationships":[{"is_past":false,"title":"Managing Director ","person":{"first_name":"Alan","last_name":"Walts","permalink":"alan-walts","image":null}},{"is_past":false,"title":"Associate","person":{"first_name":"Allison","last_name":"Robbins","permalink":"allison-robbins","image":null}}],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/sirtris-pockets-37m-in-venture-funds/2006-04-20","source_description":"Sirtris pockets $37M in venture funds","raised_amount":37000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":19,"company":{"name":"Sirtris Pharmaceuticals","permalink":"sirtris-pharmaceuticals","image":{"available_sizes":[[[150,65],"assets/images/resized/0001/9070/19070v1-max-150x150.jpg"],[[230,100],"assets/images/resized/0001/9070/19070v1-max-250x250.jpg"],[[230,100],"assets/images/resized/0001/9070/19070v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.kalobios.com/kb_news_2008_12_22.php","source_description":"KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":22,"company":{"name":"KaloBios Pharmaceuticals","permalink":"kalobios-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8539/48539v1-max-150x150.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-250x250.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.reuters.com/article/idUS91076+25-Aug-2008+BW20080825","source_description":"Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":25,"company":{"name":"Proteostasis Therapeutics","permalink":"proteostasis-therapeutics","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/0038/50038v2-max-150x150.png"],[[250,77],"assets/images/resized/0005/0038/50038v2-max-250x250.png"],[[374,116],"assets/images/resized/0005/0038/50038v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fatetherapeutics.com/pdf/20091116_PressRelease.pdf","source_description":"Fate Therapetucis","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":16,"company":{"name":"Fate Therapeutics","permalink":"fate-therapeutics","image":{"available_sizes":[[[150,26],"assets/images/resized/0006/6439/66439v1-max-150x150.png"],[[250,43],"assets/images/resized/0006/6439/66439v1-max-250x250.png"],[[450,79],"assets/images/resized/0006/6439/66439v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/glycomimetics-inc-series-c-38m/","source_description":"GlycoMimetics, Inc.: Series C $38M","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":7,"company":{"name":"GlycoMimetics","permalink":"glycomimetics","image":{"available_sizes":[[[150,32],"assets/images/resized/0006/3384/63384v1-max-150x150.png"],[[250,54],"assets/images/resized/0006/3384/63384v1-max-250x250.png"],[[361,78],"assets/images/resized/0006/3384/63384v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/genetix-raises-35m-advance-gene-therapies/2010-03-11?utm_medium=rss&utm_source=rss","source_description":"Genetix raises $35M to advance gene therapies","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":12,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.accessmylibrary.com/article-1G1-173376391/tcland-expression-series-adds.html","source_description":"TcLand expression's Series A adds 8m [euro] for biomarker work.","raised_amount":8200000,"raised_currency_code":"EUR","funded_year":2007,"funded_month":12,"funded_day":19,"company":{"name":"TcLand Expression ","permalink":"tcland-expression","image":{"available_sizes":[[[150,51],"assets/images/resized/0008/0321/80321v1-max-150x150.jpg"],[[231,79],"assets/images/resized/0008/0321/80321v1-max-250x250.jpg"],[[231,79],"assets/images/resized/0008/0321/80321v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[{"description":"plans to build a manufacturing plant in Geel, Belgium","stoned_year":2011,"stoned_month":1,"stoned_day":20,"source_url":"http://www.masshightech.com/stories/2011/01/17/daily34-Genzyme-expands-Belgium-manufacturing-plant.html","source_text":null,"source_description":"Genzyme expands Belgium manufacturing plant","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Genzyme Ventures","permalink":"genzyme-ventures"}}],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}